Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ICCC | US
0.07
1.83%
Healthcare
Biotechnology
30/06/2024
17/10/2024
3.63
3.52
3.64
3.52
ImmuCell Corporation an animal health company develops manufactures and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense a passive antibody product for the treatment of E. coli coronavirus and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk as well as to determine which quarter of the udder is mastitic; and Dual-Force First Defense including a whey protein concentrate for the nutritional and feed supplement markets. In addition it is involved in developing Re-Tain a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland Maine.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
27.6%1 month
29.0%3 months
46.0%6 months
48.1%-
-
1.21
0.68
0.38
-21.19
1.84
-
-633.70K
28.39M
28.39M
-
-25.34
-63.40
54.90
-16.10
0.20
0.18
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.37
Range1M
0.55
Range3M
0.94
Rel. volume
0.21
Price X volume
19.96K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ProMIS Neurosciences Inc. | PMN | Biotechnology | 1.045 | 31.23M | 0.48% | n/a | 0.00% |
TPST | TPST | Biotechnology | 1.15 | 31.11M | 3.60% | n/a | 119.58% |
DarT Bioscience Inc | DARE | Biotechnology | 3.6 | 30.77M | 0.56% | 0.10 | 218.34% |
Anthem Inc. CORP UNIT 050118 | ANTX | Biotechnology | 1.03 | 30.74M | -2.83% | n/a | 0.00% |
BriaCell Therapeutics Corp. Common Shares | BCTX | Biotechnology | 0.845 | 30.28M | 0.80% | n/a | 0.00% |
Fortress Biotech Inc | FBIOP | Biotechnology | 5.6 | 30.06M | 8.11% | n/a | 494.61% |
Marker Therapeutics Inc | MRKR | Biotechnology | 3.25 | 29.00M | -7.67% | n/a | 0.00% |
Kala Pharmaceuticals Inc | KALA | Biotechnology | 5.1119 | 28.02M | -2.82% | n/a | 268.29% |
Mawson Infrastructure Group Inc. Common Stock | MIGI | Biotechnology | 1.45 | 26.90M | -0.68% | n/a | 571.64% |
Akari Therapeutics Plc | AKTX | Biotechnology | 2.21 | 26.84M | -12.30% | n/a | -27.01% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -21.19 | 0.53 | Cheaper |
Ent. to Revenue | 1.84 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 1.21 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 46.04 | 72.92 | Lower Risk |
Debt to Equity | 0.68 | -1.24 | Expensive |
Debt to Assets | 0.38 | 0.25 | Expensive |
Market Cap | 28.39M | 3.78B | Emerging |